# Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)

> **NCT04473430** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 53 (actual)

## Conditions studied

- End-Stage Renal Disease
- Type 2 Diabetes

## Interventions

- **DEVICE:** Dexcom Real-time G6 Continuous Glucose Monitoring System (CGM)
- **DEVICE:** POC Glucose Testing

## Key facts

- **NCT ID:** NCT04473430
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-05
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2025-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04473430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04473430, "Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04473430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*